KATHRINE STIPANOVICH: Open Payments
NPI 1124563507 · BLUE SPRINGS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$197 in 10 payments from 7 companies in 2025. Trend: 2023 $250 · 2024 $136 · 2025 $197
Food & beverage: $197
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $51 |
| Boston Scientific Corporation | 1 | $39 |
| Novo Nordisk Inc | 2 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| PFIZER INC. | 1 | $19 |
| Tonix Medicines, Inc. | 1 | $16 |
Products named: WATCHMAN FLX, VRAYLAR, LEQVIO, TRELEGY ELLIPTA, PREVNAR 20, UBRELVY, Ozempic, Rybelsus.
Industry payments across MO — which companies pay providers there.
